Remdesivir (Veklury)

Remdesivir · Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Remdesivir (Veklury), covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID. [Phase 4]